Company News For Jan 2, 2020
Zacks Investment Research | Jan 01, 2020 10:19PM ET
- Shares of Neovasc Inc. (NASDAQ:NVCN) soared nearly 37% after the company announced that it had submitted a premarket approval application to the U.S. Food and Drug Administration for Neovasc Reducer, used in treatment of refractory angina
- Shares of Viveve Medical, Inc. (NASDAQ:VIVE) jumped 46.5% after the company announced that it has regained compliance with Nasdaq listing rules
- Shares of Seadrill Limited (NYSE:SDRL) rose 7.2% after the company reported that it has received a 3-year contract for AOD II and AOD III, which is expected to be $98 million and $101 million in value
- Shares of Urovant Sciences Ltd. (NASDAQ:UROV) rose 18.4% after the company reported submission of New Drug Application for Vibegron, used for the treatment of overactive bladder
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.